Your browser doesn't support javascript.
loading
Salvianolic Acid A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Neutrophil NETosis.
Liu, Qiang; Zhu, Cheng-Long; Li, Hui-Ru; Xie, Jian; Guo, Yu; Li, Peng; Zhao, Zhen-Zhen; Wang, Jia-Feng; Deng, Xiao-Ming.
Afiliación
  • Liu Q; Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China.
  • Zhu CL; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Li HR; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Xie J; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Guo Y; Faculty of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, China.
  • Li P; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Zhao ZZ; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Wang JF; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Deng XM; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Oxid Med Cell Longev ; 2022: 7411824, 2022.
Article en En | MEDLINE | ID: mdl-35910849
Salvianolic acid A (SAA) is one of bioactive polyphenol extracted from a Salvia miltiorrhiza (Danshen), which was widely used to treat cardiovascular disease in traditional Chinese medicine. SAA has been reported to be protective in cardiovascular disease and ischemia injury, with anti-inflammatory and antioxidative effect, but its role in acute lung injury (ALI) is still unknown. In this study, we sought to investigate the therapeutic effects of SAA in a murine model of lipopolysaccharide- (LPS-) induced ALI. The optimal dose of SAA was determined by comparing the attenuation of lung injury score after administration of SAA at three different doses (low, 5 mg/kg; medium, 10 mg/kg; and, high 15 mg/kg). Dexamethasone (DEX) was used as a positive control for SAA. Here, we showed that the therapeutic effect of SAA (10 mg/kg) against LPS-induced pathologic injury in the lungs was comparable to DEX. SAA and DEX attenuated the increased W/D ratio and the protein level, counts of total cells and neutrophils, and cytokine levels in the BALF of ALI mice similarly. The oxidative stress was also relieved by SAA and DEX according to the superoxide dismutase and malondialdehyde. NET level in the lungs was elevated in the injured lung while SAA and DEX reduced it significantly. LPS induced phosphorylation of Src, Raf, MEK, and ERK in the lungs, which was inhibited by SAA and DEX. NET level and phosphorylation level of Src/Raf/MEK/ERK pathway in the neutrophils from acute respiratory distress syndrome (ARDS) patients were also inhibited by SAA and DEX in vitro, but the YEEI peptide reversed the protective effect of SAA completely. The inhibition of NET release by SAA was also reversed by YEEI peptide in LPS-challenged neutrophils from healthy volunteers. Our data demonstrated that SAA ameliorated ALI via attenuating inflammation, oxidative stress, and neutrophil NETosis. The mechanism of such protective effect might involve the inhibition of Src activation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácidos Cafeicos / Lesión Pulmonar Aguda / Trampas Extracelulares / Lactatos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácidos Cafeicos / Lesión Pulmonar Aguda / Trampas Extracelulares / Lactatos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos